– BRUSSELS LAUNCHES FRESH CONSULTATION ON ADVANCED THERAPY MEDICINES

THE EUROPEAN Commission is considering another reform of the European Union (EU) advanced therapy regulation, asking the pharma sector for its views on a range of concerns. In a consultation document, Brussels said it was concerned that the current legislation, which was last updated in 2007, had failed to secure European Union (EU) market authorisations for combined medicinal products: “No application for a combined advanced therapy medicinal product has been submitted to the European Medicines Agency (EMA) yet”, said the Commission.Another concern that the ...


Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.